(HealthDay)—The U.S. Food and Drug Administration approved use of a higher dose of naloxone hydrochloride nasal spray for treating opioid overdose, the agency announced Friday.
(HealthDay)—The U.S. Food and Drug Administration plans to expand emergency use of Pfizer’s coronavirus vaccine by next week so that children as young as 12 can […]
(HealthDay)—The U.S. Preventive Services Task Force (USPSTF) concludes that evidence is currently insufficient for determining the benefits and harms of most single or paired and multivitamin […]